Advanced Wearable Insulin Pump System with Real-time Medication Occlusion Detection and Personalized Dosage Recommendations
Legal Citation
Summary of the Inventive Concept
An enhanced wearable insulin pump system that integrates real-time medication occlusion detection, automatic dosage adjustment, and personalized dosage recommendations to improve the safety and efficacy of medication delivery for diabetes patients.
Background and Problem Solved
The original patent, 'Systems and methods for delivering microdoses of medication,' has limitations in detecting medication occlusion and adjusting dosages accordingly. This new inventive concept addresses these limitations by incorporating advanced sensors and data analytics capabilities to ensure accurate and personalized medication delivery.
Detailed Description of the Inventive Concept
The advanced wearable insulin pump system comprises a patch pump with a built-in sensor for detecting medication occlusion. Upon detection, the system automatically adjusts the dosage accordingly. Additionally, the system includes a data analytics module that tracks the user's medication adherence and provides personalized dosage recommendations based on the user's glucose levels, activity data, and other relevant factors. The system also includes a mobile application for tracking the user's medication schedule and sending reminders and alerts.
Novelty and Inventive Step
The new inventive concept's novelty lies in the integration of real-time medication occlusion detection and automatic dosage adjustment, which is not present in the original patent. The inventive step is the use of advanced sensors and data analytics capabilities to personalize medication delivery and improve patient safety.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different types of sensors, such as optical or acoustic sensors, to detect medication occlusion. Additionally, the system could be integrated with other health monitoring devices, such as continuous glucose monitors, to provide a more comprehensive picture of the user's health.
Potential Commercial Applications and Market
The advanced wearable insulin pump system has significant commercial potential in the diabetes management market, which is expected to grow significantly in the coming years. The system's ability to improve patient safety and efficacy makes it an attractive solution for patients, healthcare providers, and payers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/14248 |
| A | A61 | A61B5/14865 |
| A | A61 | A61M5/1413 |
| A | A61 | A61M5/158 |
| A | A61 | A61M5/168 |
| A | A61 | A61M5/1684 |
| A | A61 | A61M5/16827 |
| A | A61 | A61M5/172 |
| A | A61 | A61M5/1723 |
| A | A61 | A61M5/5086 |
| A | A61 | A61M2005/14252 |
| A | A61 | A61M2005/14256 |
| A | A61 | A61M2005/14533 |
| A | A61 | A61M2005/1586 |
| A | A61 | A61M2205/18 |
| A | A61 | A61M2205/3317 |
| A | A61 | A61M2205/3331 |
| A | A61 | A61M2205/582 |
| A | A61 | A61M2207/00 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Device Technology - Specifically Wearable Insulin Delivery Systems, involving biomedical engineering, sensor technology, and drug delivery mechanisms with expertise in patch-style medical devices and personalized medication management
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with advanced degree, 3-5 years experience in medical device design, familiar with diabetes management technologies, sensor integration, and mobile health monitoring systems
Obviousness Rationale
A PHOSITA would recognize that integrating real-time sensor technology and data analytics into an existing wearable insulin pump represents a predictable technological evolution. The source patent's foundational design provides a clear framework for enhancement through sensor-based monitoring and personalized dosage adjustment. The technical variations represent incremental improvements using known techniques in medical device design and digital health monitoring.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,757 |
|---|---|
| Title | Systems and methods for delivering microdoses of medication |
| Assignee(s) | Tandem Diabetes Care Switzerland Sàrl |